Reports of Radiotherapy and Oncology. 2013; 1 (3): 97-102
em Inglês
| IMEMR
| ID: emr-173627
ABSTRACT
Introduction:
Adjuvant Online! [AOL] is used extensively by oncologists in Iran to treat patients with breast cancer; however, it has never been validated for use in Iran, and its predictions might not be applicable to Iranian patients. The aim of this study was to evaluate the usefulness of this program in predicting the outcomes of Iranian patients with breast cancer
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
Rep. Radiother. Oncol.
Ano de publicação:
2013
Similares
MEDLINE
...
LILACS
LIS